Shares of pharmaceutical companies have had it tough recently following rising incidence of warning letters from the US Food and Drug Administration (US FDA). Aurobin..
Strong CAPA required to resolve regulatory issues
* The USFDA conducted an inspection at Unit-7 of Aurobindo Pharma (ARBP) between 19th-27th Sep’19 and is..
US FDA Issues Form 483 with Seven Observations to Unit-VII
The US FDA has issued Form 483 with seven observations to Aurobindo Pharma’s (ARBP) Unit-VII facility...
Business momentum to continue — maintain LONG
ARBP’s 4Q sales/EBITDA at Rs 52.92bn/Rs 10.58bn matched EE, while PAT at Rs 6.2bn fell 7% short on higher eff..
STOCK IN FOCUS
* Aurobindo Pharma (ARBP) is a mid-sized Indian pharma company with one of the largest product portfolios in the US market. Formulation business contrib..
Better Performance across Geographies; Maintain BUY
Aided by strong growth across geographies in formulation segment, Aurobindo Pharma (ARBP) has delivered a better-th..
US traction continues
We maintain BUY on ARBP following a sizable beat on our 1QFY20 numbers. With visible traction in both US and EU businesses, we have upgraded our ..
Q1 beats; Formulation growth remains robust
The Q1FY20 sales, adj. EBITDA and PAT beat our estimates by 7%, 9% and 2% respectively. While the injectable business was i..
Strong performance on continued US scale-up
Aurobindo Pharma (Aurobindo)’s Q1FY20 earnings were better-than-our estimates across parameters. Revenue grew 28.1% Y..
Religare Super Ideas
Aurobindo Pharma Limited (AUROPHARMA)
AUROPHARMA has been hovering in a range for last three weeks, after retesting its monthly support z..
* Aurobindo Pharma (ARBP) is a mid-sized Indian pharma company with one of the largest product portfolios in the US market. Formulation business contributes ~83% to its t..
Now Get InvestmentGuruIndia.com news on WhatsApp. Click Here To Know More
Strong US growth; steady outlook
Strong US driven by Spectrum, volume gains and Ertap..
Accelya Solutions In Q4 net profit up 32.35% at Rs 24.71 cr
US dollar rises after Fed policy meeting
Rupee rises by 12 paise to Rs 69.05 against dollar
BSNL to offer more data, validity under select prepaid plans
Infosys signs agreement with U.S. IRS; sees lower tax rate
15.65 lakh cases pending in Odisha courts
Gold, Silver, Crude Oil, Copper, Nickel, Zinc Commodity Report of 19 November 2019 By Geojit Financial
U.S. breaks off defence cost talks, as South Korea balks at $5 billion demand
Yes Bank invokes pledge to take 20.6% stake in Tulip Star Hotels
© Copyright 2017 - investmentguruindia | All Rights Reserved. | Crafted By - Digi Interface